Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA.

PloS one | 2013

Defining the molecular interactions required to program activated CD8 T cells to survive and become memory cells may allow us to understand how to augment anti-viral immunity. HVEM (herpes virus entry mediator) is a member of the tumor necrosis factor receptor (TNFR) family that interacts with ligands in the TNF family, LIGHT and Lymphotoxin-α, and in the Ig family, B and T lymphocyte attenuator (BTLA) and CD160. The Ig family members initiate inhibitory signaling when engaged with HVEM, but may also activate survival gene expression. Using a model of vaccinia virus infection, we made the unexpected finding that deficiency in HVEM or BTLA profoundly impaired effector CD8 T cell survival and development of protective immune memory. Mixed adoptive transfer experiments indicated that BTLA expressed in CD8α+ dendritic cells functions as a trans-activating ligand that delivers positive co-signals through HVEM expressed in T cells. Our data demonstrate a critical role of HVEM-BTLA bidirectional cosignaling system in antiviral defenses by driving the differentiation of memory CD8 T cells.

Pubmed ID: 24205056 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: AI067890
  • Agency: NIAID NIH HHS, United States
    Id: AI67341
  • Agency: NIAID NIH HHS, United States
    Id: R56 AI067341
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI067341
  • Agency: NCI NIH HHS, United States
    Id: R01 CA091837
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI048073
  • Agency: NIAID NIH HHS, United States
    Id: AI087734
  • Agency: NIAID NIH HHS, United States
    Id: R21 AI077079
  • Agency: NIAID NIH HHS, United States
    Id: R37 AI033068
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI087734
  • Agency: NCI NIH HHS, United States
    Id: CA91837
  • Agency: NIAID NIH HHS, United States
    Id: AI048073
  • Agency: NIAID NIH HHS, United States
    Id: AI77079
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI067890
  • Agency: NIAID NIH HHS, United States
    Id: AI033068
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI033068

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

HeLa (tool)

RRID:CVCL_0030

Cell line HeLa is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions

Vero C1008 (tool)

RRID:CVCL_0574

Cell line Vero C1008 is a Spontaneously immortalized cell line with a species of origin Chlorocebus sabaeus

View all literature mentions